NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)

CUSIP: G6674U108

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Ordinary Shares, no par value per share
Shares outstanding
112,245,592
Total 13F shares
89,476,517
Share change
+4,851,329
Total reported value
$5,380,865,921
Put/Call ratio
47%
Price per share
$60.14
Number of holders
291
Value change
+$285,351,944
Number of buys
124
Number of sells
139

Quarterly Holders Quick Answers

What is CUSIP G6674U108?
CUSIP G6674U108 identifies NVCR - NovoCure Ltd - Ordinary Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q1 2023

As of 31 Mar 2023, NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by 291 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 89,476,517 shares. The largest 10 holders included FMR LLC, Capital World Investors, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, BlackRock Inc., Capital International Investors, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, T. Rowe Price Investment Management, Inc., and Nordwand Advisors, LLC. This page lists 291 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.